The pricing of carbon risk in syndicated loans: Which risks are priced and why?

被引：91

作者：

Ehlers, Torsten ^{[1
]}

Packer, Frank ^{[2
]}

de Greiff, Kathrin ^{[3
]}

机构：

[1] Bank Int Settlements, Basel, Switzerland

[2] Bank Int Settlements, Representat Off Asia & Pacific, Hong Kong, Peoples R China

[3] Univ Zurich, Zurich, Switzerland

来源：

JOURNAL OF BANKING & FINANCE | 2022年 / 136卷

关键词：

Environmental policy; Climate policy risk; Transition risk; Loan pricing;

D O I：

10.1016/j.jbankfin.2021.106180

中图分类号：

F8 [财政、金融];

学科分类号：

0202 ;

摘要：

Do banks price the risks of climate policy change? Combining syndicated loan data with carbon intensity data (CO2 emissions relative to revenue) of borrowers across a wide range of industries, we find a significant "carbon premium " since the Paris Agreement. The loan risk premium related to CO2 emission intensity is apparent across industries and broader than that due simply to "stranded assets " in fossil fuel or other carbon-intensive industries. The price of risk, however, appears to be relatively low given the material risks faced by some borrowers. Only carbon emissions directly caused by the firm (scope 1) are priced, and not the overall carbon footprint including indirect emissions. "Green " banks do not appear to price carbon risk differently from other banks. (C) 2021 Elsevier B.V. All rights reserved.

引用

页数：13

共 50 条

[21] Flood risks are insufficiently priced into housing markets but better pricing would leave some worse off
Mach, Katharine
NATURE CLIMATE CHANGE, 2023, 13 (03) : 216 - 217
[22] Loans to Chapter 11 Firms: Contract Design, Repayment Risk, and Pricing
Eckbo, B. Espen
Li, Kai
Wang, Wei
JOURNAL OF LAW & ECONOMICS, 2023, 66 (03): : 465 - 509
[23] Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform
Robinson, James C.
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (22): : 2017 - 2019
[24] When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing
Fanor Balderrama
Lisa J. Schwartz
Christopher J. Longo
Health Care Analysis, 2020, 28 : 121 - 136
[25] INNOVATIVE PRICING AND REIMBURSEMENT SCHEMES - THE WHAT, WHY, WHICH, AND HOW
Macaulay, R.
Hettle, R.
VALUE IN HEALTH, 2017, 20 (09) : A403 - A404
[26] When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing
Balderrama, Fanor
Schwartz, Lisa J.
Longo, Christopher J.
HEALTH CARE ANALYSIS, 2020, 28 (02) : 121 - 136
[27] Is Carbon Risk Priced in the Cross Section of Corporate Bond Returns?
Duan, Tinghua
Li, Frank Weikai
Wen, Quan
JOURNAL OF FINANCIAL AND QUANTITATIVE ANALYSIS, 2025, 60 (01) : 1 - 35
[28] Effect of climate-related risk on the costs of bank loans: Evidence from syndicated loan markets in emerging economies
Ho, Kelvin
Wong, Andrew
EMERGING MARKETS REVIEW, 2023, 55
[29] The credit risk in SME loans portfolios: Modeling issues, pricing, and capital requirements
Dietsch, M
Petey, J
JOURNAL OF BANKING & FINANCE, 2002, 26 (2-3) : 303 - 322
[30] Carbon risk risk and the cost of bank loans: Evidence from China
Zhu, Bo
Zhao, Yue
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 2022, 180

← 1 2 3 4 5 →